Omaveloxolone: an activator of Nrf2 for the treatment of Friedreich ataxia

Profeta, V; McIntyre, K; Wells, M; Park, C; Lynch, DR

Lynch, DR (通讯作者)，Univ Penn, Perelman Sch Med, Childrens Hosp Philadelphia, 502F Abramson Res Ctr, 3615 Civ Ctr Blvd, Philadelphia, PA 19104 USA.

EXPERT OPINION ON INVESTIGATIONAL DRUGS, 2023; 32 (1): 5

Abstract

IntroductionFriedreich ataxia (FRDA) is a rare autosomal recessive degenerative disorder characterized by ataxia, dysarthria, diabetes, cardiomyopathy......

Full Text Link


Links

期刊讨论 | 中国SCI论文 | 期刊主页 | 投稿经验 | 杂志官网 | 投稿链接 | 作者需知 | PMC链接 | Pubmed全文检索